BLOPEPBOLANG BIOTECHNOLOGY

GHRH(1–29) peptide

Sermorelin acetate

Sermorelin corresponds in the cited literature to GRF(1-29). Research compares unmodified peptide and separately modified analogues; PEGylated results do not describe this catalog item.

BLOPEP vial — representative image
Representative image
Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings →

Mechanism and findings

Mechanism of action

Sermorelin acetate — ghrh(1–29) peptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

  • GHRH receptor

Esposito et al., 2003

Sources and studies 1
  1. PEGylation of growth hormone-releasing hormone (GRF) analogues.

    Esposito P, Barbero L, Caccia P, Caliceti P, D'Antonio M, Piquet G, Veronese FM · 2003 · Advanced drug delivery reviews

    DOI: 10.1016/s0169-409x(03)00109-1

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Look up batch

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.

Other materials in this area

View category →